Trial site
Cleveland Clinic Foundation
- 307running trials
- 125closed trials
The trials here
What the 438 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers102 trials
- Lung cancer41 trials
- Ovarian cancer32 trials
- Sarcoma31 trials
- Acute lymphoblastic leukaemia28 trials
- Prostate cancer21 trials
- Kidney cancer19 trials
- Neuroblastoma19 trials
- Acute myeloid leukaemia16 trials
- Colorectal cancer14 trials
- Glioblastoma13 trials
- Endometrial cancer12 trials
- and 78 more
- Phase
- Phase 3150 trials
- Phase 2113 trials
- Phase 2/327 trials
- Phase 122 trials
- Phase 1/213 trials
- Phase 43 trials
- Status
- Active, not recruiting192 trials
- Completed112 trials
- Recruiting100 trials
- Terminated12 trials
- Not yet recruiting9 trials
- Enrolling by invitation6 trials
- Suspended6 trials
- Withdrawn1 trial
- Lead sponsor
- National Cancer Institute (NCI)123 trials
- Children's Oncology Group52 trials
- NRG Oncology23 trials
- SWOG Cancer Research Network18 trials
- Novartis Pharmaceuticals15 trials
- and 112 more
Running trials
Not yet recruiting
Not yet recruiting
Study of LusPACercept in Participants With Myelofibrosis Associated Anemia and Thrombocytopenia
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
Active, not recruiting
Recruiting
Recruiting
Enrolling by invitation
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Active, not recruiting
Recruiting
Recruiting
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Recruiting
Recruiting
Recruiting
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
Recruiting
Recruiting
Active, not recruiting
Recruiting
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Recruiting
Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Recruiting
Recruiting
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Enrolling by invitation
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Recruiting
Recruiting
Recruiting
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recruiting
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Showing 50 of 307.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers15 recruiting
- Ovarian cancer9 recruiting
- Prostate cancer7 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Lung cancer5 recruiting
- Atrial fibrillation4 recruiting
- Coronary artery disease4 recruiting
- Heart failure4 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Colorectal cancer3 recruiting
- COPD3 recruiting
- Crohn's disease3 recruiting
- Endometrial cancer3 recruiting
- Epilepsy3 recruiting
- Liver cirrhosis3 recruiting
- Metastatic breast cancer3 recruiting
- Sarcoma3 recruiting
- Stroke3 recruiting
- Ventricular tachycardia3 recruiting
- Acute myeloid leukaemia2 recruiting
- Aortic aneurysm2 recruiting
- Barrett's oesophagus2 recruiting
- Cervical cancer2 recruiting
- Chronic kidney disease2 recruiting
- Down syndrome2 recruiting
- Head and neck cancer2 recruiting
- High blood pressure2 recruiting
- Kidney cancer2 recruiting
- Multiple sclerosis2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Neuroblastoma2 recruiting
- Obesity2 recruiting
- Osteoarthritis2 recruiting
- Pancreatic cancer2 recruiting
- Rheumatoid arthritis2 recruiting
- Type 1 diabetes2 recruiting
- Aortic stenosis1 recruiting
- Bladder cancer1 recruiting
- Brain aneurysm1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Cystic fibrosis1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Depression1 recruiting
- Gastroparesis1 recruiting
- Glioblastoma1 recruiting
- Huntington's disease1 recruiting
- Hyperparathyroidism1 recruiting
- Lewy body dementia1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lupus (SLE)1 recruiting
- Mantle cell lymphoma1 recruiting
- Meningioma1 recruiting
- Multiple myeloma1 recruiting
- Nephrotic syndrome1 recruiting
- Neuroendocrine tumours1 recruiting
- Obstructive sleep apnoea1 recruiting
- Osteonecrosis (avascular necrosis)1 recruiting
- Parkinson disease1 recruiting
- Peripheral artery disease1 recruiting
- Postural tachycardia syndrome (POTS)1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Terminated
Completed
Recruiting
Terminated
Completed
Withdrawn
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
Terminated
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Completed
Completed
Motivational Enhancement - Acute Decompensated Heart Failure and OSA
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Terminated
Completed
Completed
Completed
Completed
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
Completed
Terminated
Completed
Completed
Completed
Completed
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Terminated
Completed
Completed
Completed
Completed
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Terminated
Completed
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Completed
Completed
Completed
Completed
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Completed
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Showing 50 of 125.
Site data: ClinicalTrials.govUpdated 15 Nov 2026